Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment | Zendy

Claus Garbe | Zendy; Ulrike Keim | Zendy; Teresa Amaral | Zendy; Carola Berking | Zendy; Thomas Eigentler | Zendy; Lukas Flatz | Zendy; Anja Gesierich | Zendy; Ulrike Leiter | Zendy; Rudolf Stadler | Zendy; Cord Sunderkötter | Zendy; Thomas Tüting | Zendy; Jochen Utikal | Zendy; Uwe Wollina | Zendy; Lisa Zimmer | Zendy; Christos C. Zouboulis | Zendy; Paolo A. Ascierto | Zendy; Alexander M.M. Eggermont | Zendy; JeanJacques Grob | Zendy; Axel Hauschild | Zendy; Lidija Kandolf Sekulović | Zendy; Georgina V. Long | Zendy; Jason J. Luke | Zendy; Olivier Michielin | Zendy; Ketty Peris | Zendy; Dirk Schadendorf | Zendy; John M. Kirkwood | Zendy; Paul Lorigan | Zendy

Open Access

Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment

Author(s) -

Claus Garbe,

Ulrike Keim,

Teresa Amaral,

Carola Berking,

Thomas Eigentler,

Lukas Flatz,

Anja Gesierich,

Ulrike Leiter,

Rudolf Stadler,

Cord Sunderkötter,

Thomas Tüting,

Jochen Utikal,

Uwe Wollina,

Lisa Zimmer,

Christos C. Zouboulis,

Paolo A. Ascierto,

Alexander M.M. Eggermont,

JeanJacques Grob,

Axel Hauschild,

Lidija Kandolf Sekulović,

Georgina V. Long,

Jason J. Luke,

Olivier Michielin,

Ketty Peris,

Dirk Schadendorf,

John M. Kirkwood,

Paul Lorigan

Publication year - 2022

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.22.00202

Subject(s) - medicine , melanoma , stage (stratigraphy) , cohort , cancer registry , oncology , cancer , population , adjuvant therapy , cancer research , paleontology , environmental health , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research